Dabigatran etexilate Completed Phase 1 Trials for Non-Alcoholic Fatty Liver Disease (NAFLD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03143166Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan